Skip to main content
TAVR Explant: An Emerging Necessity in the Lifetime Management of Aortic Valve Disease

TAVR Explant: An Emerging Necessity in the Lifetime Management of Aortic Valve Disease

By October 20, 2021November 11th, 2021Intervention/Structural ACS Cardiac Surgery

Journal Club - October 20, 2021

TAVR Explant: An Emerging Necessity in the Lifetime Management of Aortic Valve Disease

Dr. Gilbert Tang, Surgical Director of the Structural Heart Program at the Mount Sinai Health System, presented on the EXPLANT-TAVR International Registry.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC